Get the app!
Back to Trades

Ho Carole

DirectorCIK 0001724605

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
2
Companies
2
Active
2025–2026

Ho Carole, Director, has filed 5 reports across 2 companies, totaling $112.4K in disclosed volume. Sales ($51.7K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Jun 8RPRX
Royalty Pharma plc
Ho CaroleDirectorGrant$0
Aug 14DNLI
Denali Therapeutics Inc.
Ho CaroleChief Medical OfficerSell$51.7K
Aug 7DNLI
Denali Therapeutics Inc.
Ho CaroleChief Medical OfficerOther$0
Jul 31RPRX
Royalty Pharma plc
Ho CaroleDirectorGrant$0
Jul 25RPRX
Royalty Pharma plc
Ho CaroleDirectorOther$0

5 filings